Global Market Opportunities and Competitive Landscape for CDMO
Report Scope
This report provides an overview of the pharmaceutical business and the function of contract development and manufacturing organizations (CDMOs). The analysis includes a review of the global CDMO market by service type, drug molecule type and end use. It also examines the regulatory policies, standards and inspection trends of the global CDMO markets. In addition, the competitive environment, significant rivals, significant leaders and top 10 manufacturers in the CDMO sector are also reviewed.
The report presents a detailed description of the service types (API manufacturing services, drug product/finished drug manufacturing service, pharmaceutical development services and analytical testing and regulatory support services) and current and historical market revenues. The CDMO markets are also segmented based on type of molecule (small-molecule drugs, biologics and advanced therapies) and end user (clinical and commercial). The market revenue for each geographic segment (North America, Europe, Asia-Pacific and the Rest of the World) has also been provided in the report.
In order to provide an in-depth understanding of the market, profiles of market participants, competitive landscape, key competitors and respective market share are also included in this report. For market estimates, data has been provided for 2023 as the base year, with forecasts for 2024 through 2029.
Report Includes
76 data tables and 32 additional tables
An overview of the global contract development and manufacturing organization (CDMO) market
Analysis of the global market trends, with data from 2021-2022, estimates for 2023, forecast for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Estimates of the market size and revenue forecast for the CDMO market, and a corresponding market share analysis based on type of service, drug molecule type, end user, and region
Evaluation of the market potential and opportunities for pharmaceutical CDMOs, regulatory policies, standards and inspection trends
Identifying the pharma companies that are considered leaders in their field, as well as the technological means these companies are using to exploit their markets
A look at the competitive landscape of the global CDMO market, featuring companies contracting with a contract manufacturing outsourcer for both clinical and commercial stage manufacturing
A discussion of the ESG challenges and practices in the CDMO industry
An analysis of the market shares of key companies in the industry as well as their proprietary technologies and strategic alliances
Profiles of the leading players, including Thermo Fisher Scientific Inc., Merck KGaA, Lonza, Catalent Inc., and WuXi AppTec
Companies Mentioned
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CATALENT INC.
FUJIFILM DIOSYNTH BIOTECHNOLOGIES
LONZA
MERCK KGAA
RECIPHARM AB
SAMSUNG BIOLOGICS
SIEGFRIED HOLDING AG
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC
- Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Chapter 2 Market Overview
- Overview
- Value Chain Analysis
- Small-Molecule Drugs
- Biologics
- Advanced Therapy Medical Products
- PESTEL Analysis of the Pharmaceutical Industry
- Political Factors
- Economic Factors
- Social Factors
- Technological Factors
- Environmental Factors
- Legal Factors
- Chapter 3 Market Dynamics
- Global Market Dynamics
- Market Drivers
- Increase in Pharmaceutical Outsourcing Practices
- Pressure on R&D Spending
- Rising Demand for Advanced Therapeutics
- Upsurge in the Number of Clinical Trials
- Market Restraints
- Strict Regulations and Compliance Requirements
- Shortage of Skilled Technical Personnel
- Strong Competition in Cost, Technology and Service Ranges
- Market Opportunities
- Inorganic Growth
- Chapter 4 Emerging Trends
- Overview
- Increased Focus on Biologics and Cell and Gene Therapy
- Integration of Digital Technologies
- Collaborative Risk Management
- Chapter 5 Regulatory Landscape
- Overview
- Good Manufacturing Practice (GMP)
- Quality Assurance and Quality Control
- Regulatory Submissions
- Environmental & Safety Regulations
- International Standards
- Data Integrity & Security
- Labeling & Packaging
- Audits and Inspections
- Chapter 6 Market Segmentation Analysis
- Segmentation Breakdown
- Market Breakdown by Type of Service
- API Manufacturing Services
- Drug Product/Finished Drug Manufacturing Services
- Pharmaceutical Development Services
- Analytical Testing and Regulatory Support Services
- Market Breakdown by Type of Molecule
- Small-molecule Drugs
- Biologics
- Advanced Therapies
- Market Breakdown by End User
- Clinical
- Commercial
- Geographic Breakdown
- Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Chapter 7 Competitive Intelligence
- Overview
- New Entrants in Market
- Global Market Shares of Leading Companies
- Chapter 8 Sustainability in CDMO Market: ESG Perspective
- Overview
- Green Chemistry and Pharmaceutical Manufacturing
- Considering Sustainability through the Development Cycle and Across the Supply Chain
- Sustainability in the CDMO industry
- Environmental Considerations
- Social Considerations
- Governance Factors
- ESG Risk Ratings
- Conclusion
- Chapter 9 Appendix
- Methodology
- Sources
- Abbreviations
- Company Profiles
- BOEHRINGER INGELHEIM INTERNATIONAL GMBH
- CATALENT INC.
- FUJIFILM DIOSYNTH BIOTECHNOLOGIES
- LONZA
- MERCK KGAA
- RECIPHARM AB
- SAMSUNG BIOLOGICS
- SIEGFRIED HOLDING AG
- THERMO FISHER SCIENTIFIC INC.
- WUXI APPTEC
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook